‘Fifth Day Fits’ (FDF) – Biotinidase Deficiency is Probably the New Name

Kumar RK^1,2,3*, Shah P^4
1Senior Consultant Neonatologist & Paediatrician, Cloudnine Hospitals, Bangalore, India
²Visiting Consultant Neonatologist, Indira Gandhi Institute of Child Health, Bangalore, India
³Adjunct Professor in Neonatology & Paediatrics, Notre Dame University, Perth, Australia
⁴Fellowship in Neonatal Intensive Care, Perth, Australia

Corresponding Author: R. Kishore Kumar ^{ORCID iD}
Address: Consultant Neonatologist & Paediatrician, Cloudnine Hospital, 1533, 3^rd Block Jayanagar, 9^th Main, Bangalore - 560011, India.
Received date: 26 November 2020; Accepted date: 26 December 2020; Published date: 03 January 2021

Citation: Kumar RK, Shah P. ‘Fifth Day Fits’ (FDF) – Biotinidase Deficiency is Probably the New Name. Asp J Pediatrics Child Health. 2021 Jan 03;2(3):58-61.

Copyright © 2020 Kumar RK, Shah P. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Neonatal Seizures, Biotinidase Deficiency, Metabolic Screening

Abstract

Neonatal Seizures, the most critical of neonatal neurologic dysfunction, has aetiology of varying prognoses. The diagnosis of underlying aetiology is most critical. With use of genetic studies, better imaging technologies, better cortical electrical activity mapping and biochemical advancement, every attempt in diagnosing a cause is made.